The more significant trend is the chronic shift where companies are deliberately increasing their share of chronic prescriptions (cardiac, diabetes, respiratory) which offer more predictable, annuity-like revenue versus seasonal acute therapies
For details on how much of a supplement to take, see the article: Vitamin B12 Dosages
Child AH, Gordon KD, Sharpe P, et al
In summary, our data demonstrate that via GIP signalling linagliptin is able to retain its ability to improve glucose tolerance in mice devoid of Gcg -encoded peptides, including GLP-1 and oxyntomodulin (two targets of DPP-4 degradation)
Originally developed for type 2 diabetes, semaglutide is now FDA-approved for weight management with options like Wegovy